Panel Discussion: The 2023 Market Outlook: What Are Venture Capital Looking for in Ophthalmic Gene Therapy Companies?

Time: 4:20 pm
day: Conference Day One


  • Outlining the current venture capital investment landscape for gene therapy in the ophthalmology field
  • What are investors looking for when it comes to developing preclinical, clinical, and manufacturing packages in the most fruitful, cost-effective manner?
  • Key considerations for developing realistic fundraising timelines